Cargando…

Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19

BACKGROUND: Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Hirsh D., Wilechansky, Robert, Goyes, Daniela, Vieira Barbosa, Joana, Canakis, Andrew, Lai, Michelle, Long, Michelle T., Fricker, Zachary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256898/
https://www.ncbi.nlm.nih.gov/pubmed/34267833
http://dx.doi.org/10.14740/gr1389
_version_ 1783718190175485952
author Trivedi, Hirsh D.
Wilechansky, Robert
Goyes, Daniela
Vieira Barbosa, Joana
Canakis, Andrew
Lai, Michelle
Long, Michelle T.
Fricker, Zachary
author_facet Trivedi, Hirsh D.
Wilechansky, Robert
Goyes, Daniela
Vieira Barbosa, Joana
Canakis, Andrew
Lai, Michelle
Long, Michelle T.
Fricker, Zachary
author_sort Trivedi, Hirsh D.
collection PubMed
description BACKGROUND: Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. METHODS: We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care unit use, mechanical ventilation, and in-hospital mortality. We used Mann-Whitney U-test for continuous measures and Chi-square or Fisher’s exact test for categorical measures. Multivariable linear and logistic regression analyses were used to adjust for confounders. RESULTS: Of the 319 patients, 14% had hepatic steatosis. There were no differences in length of stay (6 (4 - 16) vs. 9 (4 - 18) days, P = 0.6), intensive care unit (24% vs. 32%, P = 0.3), mechanical ventilation (28% vs. 38%, P = 0.32), or in-hospital mortality (7% vs. 17%, P = 0.12). After adjustment, there was no difference in length of stay (β: -14.37, 95% confidence interval (CI): -30.5 - 1.77, P = 0.08), intensive care unit (odds ratio (OR): 0.31, 95% CI: 0.03 - 1.09, P = 0.06), mechanical ventilation (OR: 0.13, 95% CI: 0.02 - 1.09, P = 0.06), or in-hospital mortality (OR: 0.27, 95% CI: 0.06 - 1.16, P = 0.08) among patients with hepatic steatosis. CONCLUSION: Radiographic hepatic steatosis was not associated with worse outcomes among patients hospitalized with COVID-19.
format Online
Article
Text
id pubmed-8256898
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-82568982021-07-14 Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19 Trivedi, Hirsh D. Wilechansky, Robert Goyes, Daniela Vieira Barbosa, Joana Canakis, Andrew Lai, Michelle Long, Michelle T. Fricker, Zachary Gastroenterology Res Original Article BACKGROUND: Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort. METHODS: We retrospectively identified patients with COVID-19 infection admitted to two US academic hospitals. Outcomes were length of stay, intensive care unit use, mechanical ventilation, and in-hospital mortality. We used Mann-Whitney U-test for continuous measures and Chi-square or Fisher’s exact test for categorical measures. Multivariable linear and logistic regression analyses were used to adjust for confounders. RESULTS: Of the 319 patients, 14% had hepatic steatosis. There were no differences in length of stay (6 (4 - 16) vs. 9 (4 - 18) days, P = 0.6), intensive care unit (24% vs. 32%, P = 0.3), mechanical ventilation (28% vs. 38%, P = 0.32), or in-hospital mortality (7% vs. 17%, P = 0.12). After adjustment, there was no difference in length of stay (β: -14.37, 95% confidence interval (CI): -30.5 - 1.77, P = 0.08), intensive care unit (odds ratio (OR): 0.31, 95% CI: 0.03 - 1.09, P = 0.06), mechanical ventilation (OR: 0.13, 95% CI: 0.02 - 1.09, P = 0.06), or in-hospital mortality (OR: 0.27, 95% CI: 0.06 - 1.16, P = 0.08) among patients with hepatic steatosis. CONCLUSION: Radiographic hepatic steatosis was not associated with worse outcomes among patients hospitalized with COVID-19. Elmer Press 2021-06 2021-06-19 /pmc/articles/PMC8256898/ /pubmed/34267833 http://dx.doi.org/10.14740/gr1389 Text en Copyright 2021, Trivedi et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Trivedi, Hirsh D.
Wilechansky, Robert
Goyes, Daniela
Vieira Barbosa, Joana
Canakis, Andrew
Lai, Michelle
Long, Michelle T.
Fricker, Zachary
Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19
title Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19
title_full Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19
title_fullStr Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19
title_full_unstemmed Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19
title_short Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19
title_sort radiographic hepatic steatosis is not associated with key clinical outcomes among patients hospitalized with covid-19
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256898/
https://www.ncbi.nlm.nih.gov/pubmed/34267833
http://dx.doi.org/10.14740/gr1389
work_keys_str_mv AT trivedihirshd radiographichepaticsteatosisisnotassociatedwithkeyclinicaloutcomesamongpatientshospitalizedwithcovid19
AT wilechanskyrobert radiographichepaticsteatosisisnotassociatedwithkeyclinicaloutcomesamongpatientshospitalizedwithcovid19
AT goyesdaniela radiographichepaticsteatosisisnotassociatedwithkeyclinicaloutcomesamongpatientshospitalizedwithcovid19
AT vieirabarbosajoana radiographichepaticsteatosisisnotassociatedwithkeyclinicaloutcomesamongpatientshospitalizedwithcovid19
AT canakisandrew radiographichepaticsteatosisisnotassociatedwithkeyclinicaloutcomesamongpatientshospitalizedwithcovid19
AT laimichelle radiographichepaticsteatosisisnotassociatedwithkeyclinicaloutcomesamongpatientshospitalizedwithcovid19
AT longmichellet radiographichepaticsteatosisisnotassociatedwithkeyclinicaloutcomesamongpatientshospitalizedwithcovid19
AT frickerzachary radiographichepaticsteatosisisnotassociatedwithkeyclinicaloutcomesamongpatientshospitalizedwithcovid19